Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation.
about
Cryptococcus and Phagocytes: Complex Interactions that Influence Disease OutcomeData mining of atherosclerotic plaque transcriptomes predicts STAT1-dependent inflammatory signal integration in vascular disease.Macrophage activation state determines the response to rhinovirus infection in a mouse model of allergic asthma.Very low levels of 25-hydroxyvitamin D are not associated with immunologic changes or clinical outcome in South African patients with HIV-associated cryptococcal meningitis.STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice.Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages.Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitisInnate Defense against Fungal PathogensIs Development of a Vaccine against Cryptococcus neoformans Feasible?Cryptococcal heat shock protein 70 homolog Ssa1 contributes to pulmonary expansion of Cryptococcus neoformans during the afferent phase of the immune response by promoting macrophage M2 polarizationCryptococcus neoformans Infection in Mice Lacking Type I Interferon Signaling Leads to Increased Fungal Clearance and IL-4-Dependent Mucin Production in the Lungs.Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants.STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformansThe Cnes2 locus on mouse chromosome 17 regulates host defense against cryptococcal infection through pleiotropic effects on host immunityThe phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis.Antifungal Activity of Plasmacytoid Dendritic Cells against Cryptococcus neoformans In Vitro Requires Expression of Dectin-3 (CLEC4D) and Reactive Oxygen Species.Cryptococcus: from environmental saprophyte to global pathogen.The intracellular life of Cryptococcus neoformans.Impact of surfactant protein D, interleukin-5, and eosinophilia on Cryptococcosis.Macrophage Cryptococcus interactions: an update.Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment.Cryptococcus antigens and immune responses: implications for a vaccine.Classical versus alternative macrophage activation: the Ying and the Yang in host defense against pulmonary fungal infections.Immunity to Cryptococcus neoformans and C. gattii during cryptococcosisAcute Penicillium marneffei infection stimulates host M1/M2a macrophages polarization in BALB/C miceRole of dendritic cell-pathogen interactions in the immune response to pulmonary cryptococcal infection.Innate host defenses against Cryptococcus neoformans.Cryptococcus neoformans and gattii promote DNA damage in human peripheral blood mononuclear cells.T Cell-Restricted Notch Signaling Contributes to Pulmonary Th1 and Th2 Immunity during Cryptococcus neoformans Infection.Pulmonary cryptococcosis in a ruxolitinib-treated patient with primary myelofibrosisExploitation of Scavenger Receptor, Macrophage Receptor with Collagenous Structure, by Cryptococcus neoformans Promotes Alternative Activation of Pulmonary Lymph Node CD11b+ Conventional Dendritic Cells and Non-Protective Th2 Bias.Induction of Broad-Spectrum Protective Immunity against Disparate Cryptococcus Serotypes.The F-Box Protein Fbp1 Shapes the Immunogenic Potential of Cryptococcus neoformans.Organ-specific mechanisms linking innate and adaptive antifungal immunity.Innate Immunity against Cryptococcus, from Recognition to Elimination.IFN-γ immune priming of macrophages in vivo induces prolonged STAT1 binding and protection against Cryptococcus neoformansIsolation and characterisation of alveolar type II pneumocytes from adult bovine lung
P2860
Q26767978-B18596CC-4832-4431-8AB5-F1A3D24D6657Q30848049-8BD71F45-5738-4BB9-B5C8-1490BD55CD27Q33791469-38CDF240-61EC-442B-8726-AADE2BADD07CQ33953918-CE1D4757-7435-47D6-A438-29C8AB565218Q34289451-483F0A7E-F98B-48B0-B3EE-BDC5CB85E91DQ35049340-02391FB2-F2ED-44BC-8015-E5DF74B050A8Q35324835-D467D3A1-9F45-49C2-8A77-832A78501600Q35589587-EEA47F27-1A03-4DD5-A187-0C4788F1CAF4Q35667534-7C664B8C-DEE8-4DEF-8D0C-B9B403026754Q35691068-B201A444-C20D-4E33-B5B5-93CDFB2D7549Q35780552-3D1E513B-FEA2-477A-83E7-1CC9B5085815Q36177560-14BB8429-2428-4D6A-8383-E1D97BA974ACQ36281328-AD650620-C3A0-4CF2-B0AA-FBD00013E0D2Q36281331-32EA249C-D30D-4004-B14D-F505E2CA1BC7Q36846260-9D96C800-2458-4F28-A124-780A12237B8BQ37199814-D57FF67E-C550-4667-B76D-C468F451E389Q37250158-D72A879E-91D8-40FC-B42B-207924A288F0Q37452401-91744321-66E7-4CBF-B65D-9381A558B709Q37546446-EA8C6F9F-7EF8-44C3-8780-758BE7E2C4CCQ37645657-6826F4F5-76AC-4761-B90A-77932FC623B8Q38154164-601B213D-E4EB-4CBC-8AE5-F9E199F87EA5Q38155197-78F1A463-7022-46B0-977C-6C92BB2E2380Q38235148-BC91773E-5E9C-4A63-9B2C-2F263DFA886DQ38286732-172597A1-C5FE-4D32-A69A-E38448F5E090Q38618231-A6C91F49-BA46-4DD6-8339-72FEA9BD66C3Q38644509-AE251D9A-9D3E-489B-9B1F-1C517A971AF5Q38752388-FE9F78A9-4462-438D-84BA-BAD6E85412F3Q38875108-5297995F-4DEE-4BFD-BCA9-E1018CB3908DQ40172231-A0B23D27-6A7D-4D92-BC32-13CF704CA6ADQ40954119-B92FDD6B-8150-4B8C-B21D-8CD43815FB80Q42369084-0A16402C-7A40-46AA-ADF7-E61E7E47F5BAQ47118458-FA9A7C3A-5ABC-411E-B44C-E77C29D18865Q47215796-16CC8D67-723F-4263-A711-6D8AA315379FQ49795904-70BE02F8-76F4-4D09-A187-A788D0652F6BQ55421879-943AE2BD-4E50-494C-90C8-19E726053B98Q57286224-B65A0850-3B7A-4D1B-BE76-81ACECA336CBQ58793913-C2A46044-6E77-49B0-9CB7-ED49F9564043
P2860
Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Protective immunity against pu ...... assical macrophage activation.
@ast
Protective immunity against pu ...... assical macrophage activation.
@en
type
label
Protective immunity against pu ...... assical macrophage activation.
@ast
Protective immunity against pu ...... assical macrophage activation.
@en
prefLabel
Protective immunity against pu ...... assical macrophage activation.
@ast
Protective immunity against pu ...... assical macrophage activation.
@en
P2093
P2860
P356
P1476
Protective immunity against pu ...... assical macrophage activation.
@en
P2093
Camaron R Hole
Floyd L Wormley
Gina Herrera
Karen L Wozniak
Mattie L Young
Sarah E Hardison
P2860
P304
P356
10.4049/JIMMUNOL.1103455
P407
P577
2012-09-14T00:00:00Z